جست‌وجوی استاد و پژوهشگر

Seth Shipmanمشاهده پروفایل

دانشیار

• Neurodevelopmental Diseases
• Neurodegenerative Diseases
• Pharmacogenomics
• +۷ مورد دیگر

Seth Shipman is an Associate Professor at the University of California San Francisco (UCSF) within the Department of Bioengineering and Therapeutic Sciences. He holds a joint appointment as an Associate Investigator at the Gladstone Institute of Data Science and Biotechnology, where his research intersects molecular biotechnology with neurodevelopmental and neurodegenerative disease studies. His work emphasizes pharmacogenomics, genomics, and therapeutic bioengineering, leveraging DNA as a programmable biological polymer for data storage and targeted therapeutics. Education: PhD in Biochemistry and Biophysics (2012), University of California San Francisco Dr. Shipman's research focuses on overcoming technical barriers in disease understanding and treatment through molecular engineering. His lab specializes in CRISPR-Cas systems, retron gene editors, and DNA-based cellular recording technologies. Key areas include neurodevelopmental mechanisms, progressive neurodegeneration, and context-specific gene therapies. Scientific awards highlight his contributions: NIH Director’s New Innovator Award (2020), Pew Biomedical Scholar (2020), and recognition in ScienceNews as a top scientist (2019). His work has been featured in journals like Nature , Nature Biotechnology , and Science , with recent publications analyzing retron systems for genome editing and transcriptional recording in E. coli. Notable Awards: NIH Director’s New Innovator Award (2020) Pew Biomedical Scholar (2020) ScienceNews SN 10: Scientists to Watch (2019) DARPA Riser (2018) The Shipman Lab develops innovative tools like CRISPR-Cas encoding for digital movie storage in bacterial genomes (2017) and retron arrays for multi-site genome editing (2024). Their work bridges synthetic biology and clinical applications, particularly for diseases involving cellular change dynamics.

Don DeVoeمشاهده پروفایل

استاد

• MEMS and Microsystems Technology
• Microfluidic Systems
• Additive Manufacturing at Micro/Nano Scales
• +۵ مورد دیگر

Don DeVoe is a Wilson H. Elkins Professor and Associate Chair of Research & Administration in the Department of Mechanical Engineering at the University of Maryland, College Park . He holds affiliate appointments in Bioengineering and Chemical and Biomolecular Engineering, and is a core faculty member at the Robert E. Fischell Institute for Biomedical Devices. Ph.D., University of California, Berkeley (1997) M.S., University of Maryland, College Park (1993) B.S., University of Maryland, College Park (1991) Dr. DeVoe's research focuses on MEMS and microfluidic systems for biomedical applications, including nucleic acid diagnostics , exosome isolation , liposomal nanomedicine development , and viral aerobiology . His work bridges microscale engineering with clinical translation and scalable manufacturing solutions. His publications highlight innovations in 3D printed microfluidic devices , thermoplastic disposable diagnostics , and high-throughput nanomedicine synthesis . Key projects include microhydrocyclones for exosome separation, synthetic eukaryotic cell construction, and trap array chips for antibiotic resistance screening. Fellow, American Institute for Medical and Biological Engineering (2022) Fellow, Royal Society of Chemistry (2021) Wilson H. Elkins Professorship (2020) University System of Maryland Regents Award for Research (2013) NSF PECASE and CAREER Awards Dr. DeVoe served as Senior Editor for the IEEE/ASME Journal of MicroElectroMechanical Systems and currently holds leadership roles in the Chemical and Biological Microsystems Society . He directs the Maryland MEMS & Microfluidics Laboratory , with affiliations to the Maryland Robotics Center, Maryland Nanocenter, and Greenebaum Cancer Center.

Antonio R. Moreiraمشاهده پروفایل

استاد

• Bioprocess Engineering
• Microbial Fermentation
• Cell Culture Technology
• +۳ مورد دیگر

Antonio R. Moreira is a Professor in the Department of Chemical, Biochemical and Environmental Engineering at the University of Maryland, Baltimore County (UMBC). He also serves as Vice Provost for Academic Affairs, overseeing units such as the Library & Gallery, Center for Global Engagement, and the Hilltop Institute, while maintaining teaching and research responsibilities. Education: Post-doctoral in Biochemical Engineering (University of Waterloo, Canada), Ph.D. in Chemical and Biochemical Engineering (University of Pennsylvania), M.S. in Chemical and Biochemical Engineering (University of Pennsylvania), B.S. in Chemical Engineering (University of Porto, Portugal). Dr. Moreira’s research focuses on bioprocess engineering, applying engineering principles to biological processes such as microbial fermentation, cell culture, and biodownstream processing. His work emphasizes integration of bioreactor systems, mass transfer optimization, and biopharmaceutical production. Recent publications explore high-throughput clone selection, process scouting devices, and synthetic biology applications. He contributes to academic leadership by coordinating new program development, representing UMBC in international academic agreements, and chairing committees like the UMBC Diversity Council. As Director of UMBC’s Biochemical Regulatory Engineering program, he bridges engineering and pharmaceutical standards. Scientific Roles: International Board of Directors, International Society for Pharmaceutical Engineering Associate Editor, Parenteral Drug Association’s Journal of Pharmaceutical Science and Technology

Conroy Sunمشاهده پروفایل

دانشیار

• Drug Delivery
• Synthetic Biology
• Nanotechnology
• +۴ مورد دیگر

Conroy Sun is an Associate Professor at the College of Engineering, Oregon State University , affiliated with the Pharmaceutical Sciences department. His research focuses on Nanotechnology for Cancer Therapy and Biomedical Imaging , integrating material science and clinical collaborations. Education : PhD in Materials Science & Engineering (University of Washington, 2008), Postdoctoral Fellow in Radiation Oncology (Stanford, 2009-2014). Research Interests : Developing Drug Delivery Platforms using nanomaterials to enhance cancer treatments. Pioneering Synthetic Biology approaches for Molecular Imaging , including X-ray Luminescence Computed Tomography (XLCT) . Engineering Stimuli-Responsive Nanocarriers for controlled drug release and Photodynamic Therapy . Collaborations : Key partnerships with Stanford's Molecular Imaging Program and interdisciplinary teams in Pharmaceutical Sciences . Key Technologies : Radioluminescent nanoparticles, lipid-based micellar formulations, and Chlorotoxin-Conjugated Probes for Blood-Brain Barrier penetration.

• Algal Biotechnology
• Bioenergy
• Synthetic Biology
• +۳ مورد دیگر

Dr. Alexander Einhaus is a researcher affiliated with the Faculty of Biology at Bielefeld University , specifically contributing to the Algal Biotechnology and Bioenergy working group within the Center for Biotechnology (CeBiTec) . His work focuses on leveraging microalgae for sustainable bioproduction through advanced genetic and metabolic engineering. Contact details include a phone number +49 521 106-12289 and office location UHG G2-152 . Research Interests: Dr. Einhaus specializes in algal biotechnology , bioenergy , and synthetic biology , with a particular emphasis on optimizing Chlamydomonas reinhardtii as a platform organism for industrial biotechnology. His projects involve pathway engineering, CRISPR/Cas9 gene editing, and promoter design to enhance terpenoid and polyamine synthesis. Laboratories and Collaborations: He operates within the Algal Biotechnology and Bioenergy working group under CeBiTec, which is part of Bielefeld University’s interdisciplinary research ecosystem. His work intersects with strategic research areas such as the Socio-Technical World , supported by collaborations in centers like the Center for Cognitive Interaction Technology (CITEC) and CoR-Lab .

Raman Srivatsanمشاهده پروفایل

دانشیار

• Biomolecular Folding & Interactions
• Chemical Biology & Enzymology
• Quantitative Biology
• +۷ مورد دیگر

Raman Srivatsan is an Associate Professor in the Department of Bacteriology at the University of Wisconsin-Madison, with affiliate appointments in the Department of Chemical and Biological Engineering. He maintains additional affiliations with the Great Lakes Bioenergy Research Center and the Center for Genome Science Innovation, reflecting the interdisciplinary nature of his research program that bridges biochemistry, microbiology, computation, and engineering. His educational background includes a B.S. from Baroda University in India, an M.S. from Missouri University of Science and Technology, a Ph.D. from the University of Washington, Seattle, and postdoctoral training at Harvard Medical School - Wyss Institute for Biologically-inspired Engineering. Dr. Srivatsan's research program develops technologies at the intersection of multiple disciplines to understand and engineer biological systems at protein-wide and genome-wide scales. His laboratory takes a systems and synthetic biology approach, leveraging computational protein design, next-generation DNA synthesis and sequencing technologies, and highly multiplexed selection and screening assays. A common theme in his work is devising experimental screens to make thousands to millions of mutational perturbations and measurements in biological systems in single-pot experiments, which reveal functional landscapes, uncover non-intuitive sequence-function relationships, and train machine learning models for engineering new functions. Analysis of his recent publication record shows a strong focus on bacteriophage engineering, protein allostery, and high-throughput approaches to understanding biological systems. His work combines deep mutational scanning with computational methods to address fundamental questions in biomolecular systems while maintaining close alignment with translational applications in areas like antibiotic resistance and microbiome engineering. Dr. Srivatsan's research spans several interconnected areas including protein allostery (molecular rules and engineering biosensors), bacteriophage host interactions (understanding interactions, phage-based antibacterial therapies, precision microbiome editing), human disease variants, and emerging themes in transporters, gene delivery systems, and vaccine design. His laboratory's approach enables the development of programmable synthetic phages, novel allosteric biosensors, and precision tools for microbiome editing with significant potential for addressing antibiotic resistance and other biomedical challenges.

Oskar Stauferمشاهده پروفایل

پژوهشگر

• Immunomaterials
• Synthetic Cells
• Immuno-Engineering
• +۲ مورد دیگر

Oskar Staufer is a Research Group Leader at the Leibniz Institute for New Materials (INM) in Saarbrücken, Germany, and an Adjunct Research Group Leader at the Max Planck Bristol Center. He holds a PhD in Biology from Heidelberg University and has pursued postdoctoral work at the University of Oxford and Max Planck Institute. His research focuses on immuno-materials —designing materials to interact with the immune system for therapeutic applications in diseases like cancer. PhD: Heidelberg University (2017-2020) Postdoc: University of Oxford (2021-2022) Staufer's work combines material science and immunology to create synthetic cells and biomaterials that modulate immune responses. His publications and collaborations emphasize extracellular vesicles , T cell expansion , and nano-biomedical interfaces . Scientific Awards Emmy Noether Research Group Leader (German Science Foundation) Otto Hahn Medal (Max Planck Society) Young Investigator Award (International Society of Extracellular Vesicles) Karl-von-Frisch Award (German Life Science Organization) Marie Skłodowska Curie Individual Postdoctoral Fellowship At INM, Staufer leads the Pharmaceutical Research Alliance Saarland (PRAS) , leveraging technology transfer infrastructure to translate fundamental insights into clinical applications. He advocates for interdisciplinary collaboration and flexible working models, including part-time arrangements, to support work-life balance.

• Synthetic Biology
• Systems Biology
• Microbiology
• +۴ مورد دیگر

Daniel Zielinski is a Consultant Lecturer at the Novo Nordisk Foundation Center for Biosustainability within the Technical University of Denmark (DTU) . His research focuses on Synthetic Biology , Systems Biology , and Microbiology , with applications in Biotechnology and Bioinformatics . Research Contributions: Zielinski's work addresses microbial strain design, particularly for Escherichia coli and probiotic Lactobacillus reuteri . His recent publications highlight advancements in metabolic engineering , transcriptional regulatory networks , and pangenome knowledgebase (PanKB). He employs machine learning and transcriptomics to optimize biocatalysts and study bacterial persistence. Publications & Trends: Zielinski's 2025 articles focus on Escherichia coli metabolic coupling and pangenome data integration, while his 2024 work explores probiotic network modeling. Earlier studies (2021) emphasize data-driven strain design via adaptive evolution mutational data. Laboratory & Collaborations: He is affiliated with the Novo Nordisk Foundation Center for Biosustainability , collaborating with researchers like Bernhard Palsson and Paul Feist on microbial genome engineering and biocatalyst optimization.

Sean M. Wuمشاهده پروفایل

استاد

• Cardiovascular Developmental Biology
• Stem Cell Biology
• Cardiovascular Tissue Engineering
• +۵ مورد دیگر

Sean M. Wu is a Professor of Medicine (Cardiovascular Medicine) and Professor (by courtesy) of Pediatrics at Stanford University School of Medicine . He directs a multidisciplinary laboratory focused on cardiovascular developmental biology, stem cell research, and cardiac tissue engineering. Dr. Wu is a board-certified cardiologist with clinical expertise in coronary artery disease, arrhythmias, cardio-oncology, and congenital heart disease. Education: BS in Mechanical Engineering and Biological Science from Stanford (1992), PhD in Pathology from Duke (1998), MD from Duke (1999) Clinical Training: Internal Medicine Residency at Duke (2001), Cardiovascular Disease Fellowship at MGH (2005-2008) Research Interests: His work spans four major areas: Cardiovascular Developmental Biology: Using murine models to study heart chamber formation and congenital heart disease mechanisms Cardiovascular Tissue Engineering: Developing 3D bioprinted functional cardiac tissues with vascularization Disease Modeling: Human iPSC-based platforms for studying cardiac development and pathology Regenerative Biology: Exploring stem cell therapies for heart failure and conduction system repair Scientific Leadership: Dr. Wu serves as Senior Vice Chair for Academic Affairs in Stanford's Department of Medicine and Chair-Elect of the AHA Basic Cardiovascular Sciences Council. His lab's recent work has demonstrated breakthroughs in: Automated single-cell annotation via devCellPy Cardiac conduction system molecular targeting Cardiomyocyte proliferation pathway regulation Immune mechanisms in checkpoint inhibitor myocarditis Human-scale synthetic vasculature design Scientific Honors: Dr. Wu has received numerous awards including: NIH Director's Pioneer Award (2014-2019) NIH New Innovator Award (2008-2013) Election to the Association of University Cardiologists (2023) American Heart Association Established Investigator Award (2017-2021) David Lawrence Stein Award (2014) Academic Impact: With over 170 publications and 28 featured works, Dr. Wu has pioneered: First hiPSC cardiac differentiation protocols with Wnt modulation Single-cell transcriptomic atlases of human cardiac development Cardiac conduction system imaging tools Computational frameworks for organ-scale bioprinting

Vassily Hatzimanikatisمشاهده پروفایل

دانشیار

• Computational Systems Biology
• Metabolic Engineering
• Biotechnology
• +۳ مورد دیگر

Dr. Vassily Hatzimanikatis is an Associate Professor of Chemical Engineering and Bioengineering at the Swiss Federal Institute of Technology Lausanne (EPFL), holding primary appointments in the School of Basic Sciences (SB) and cross-appointments in the School of Life Sciences (SV). He directs research at the Laboratory of Computational Systems Biotechnology (LCSB) within the Institute of Chemical Sciences and Engineering (ISIC), with additional roles in the Swiss Center for Scientific Computing (SCGC) and Institute of Bioengineering (IBI-SV). His educational background includes a PhD in Chemical and Biological Engineering from the California Institute of Technology (1991-1997) and a Diploma (Master) in Chemical Engineering from the University of Patras, Greece (1986-1991). Prior to EPFL, he served as a research group leader at ETH Zurich and held positions at DuPont, Cargill, and Northwestern University. Hatzimanikatis' research centers on computational systems biology and metabolic engineering, with emphasis on kinetic modeling of metabolic networks, complexity reduction techniques, and strain design for bioproduction. His work bridges theoretical frameworks with industrial applications in pharmaceuticals and biotechnology, focusing on genome-scale models that integrate thermodynamics, expression constraints, and machine learning approaches. Analysis of his 2023-2025 publications reveals three dominant trends: 1) Integration of generative AI with kinetic parameter inference for metabolic networks, 2) Development of model reduction techniques for analyzing complex microbial communities and host-pathogen interactions, and 3) Thermodynamics-driven strain design for optimizing bioproduction while minimizing cellular burden. His recent work increasingly incorporates CRISPR genomics and machine learning to address challenges in pathogen metabolism and sustainable chemical production. His scientific recognition includes: Fellow of the American Institute for Medical and Biological Engineering (2010) DuPont Young Professor Award (2001-2004) Jay Bailey Young Investigator Award in Metabolic Engineering (2000) ACS Elmar Gaden Award (2011) Hatzimanikatis has advised 43 PhD students (8 current, 35 past) across chemical engineering and bioengineering disciplines. His teaching portfolio includes core courses in chemical engineering fundamentals, bioreactor modeling, and systems biology principles. Research funding derives from both industrial partnerships (notably DuPont and Cargill) and Swiss national science foundations, supporting his laboratory's development of computational tools like NICEpath and ATLASx. The Laboratory of Computational Systems Biotechnology (LCSB) operates as a multidisciplinary hub where computer scientists, engineers, and biologists collaborate on developing genome-scale kinetic models, metabolic network reconstructions, and AI-driven design frameworks for biotechnology applications ranging from malaria treatment to sustainable bioplastics production.

Jeffrey Ketterlingمشاهده پروفایل

استاد

• Ultrasound Imaging
• Medical Device Development
• Biomedical Engineering
• +۶ مورد دیگر

Jeffrey Ketterling is a Professor of Biomedical Engineering in the Department of Radiology at Weill Cornell Medical College since 2022. With over 25 years of experience in ultrasound research, he pioneers high-frequency ultrasound (>20 MHz) and plane-wave imaging technologies for ophthalmic and small-animal applications. Education : Ph.D. and M.Phil. in Engineering from Yale University (1999, 1997), M.S. from Yale (1996), B.S. from University of Washington (1994) Research Focus: Dr. Ketterling’s work bridges ultrasound transducer design (e.g., annular arrays, CMUT arrays), intraocular pressure dynamics, and clinical translation of imaging modalities. His innovations include: Patented annular-array transducer fabrication High-speed plane-wave imaging for blood flow quantification Acoustic nanodrop activation for microcirculation mapping Deep learning frameworks for embryonic mouse imaging Publication Trends: Recent studies emphasize machine-independent quantitative ultrasound for vitreous floaters, vortex flow analysis in cardiac models, and deep learning-enhanced segmentation of 3D ultrasound data. Collaborative efforts span ophthalmology, cardiology, and biomedical engineering domains. Research Funding: Principal Investigator for NIH grants including: National Institute of Biomedical Imaging & Bioengineering (2022–2025): 3D Annular-Array Ultrasound for Vitreo-Retinal Disease National Heart, Lung, & Blood Institute (2022–2026): High-Frequency 2D Row-Column CMUT Arrays for Cardiac Imaging Labs & Teams: Leads a multidisciplinary team developing next-generation ultrasound systems, collaborating with ophthalmologists and biomedical engineers to advance in utero and clinical imaging protocols.

• Microfluidics
• Artificial Cells
• Biomedical Engineering
• +۵ مورد دیگر

Xavier Casadevall i Solvas is a Senior Lecturer at the Faculty of Bioscience Engineering, KU Leuven, with active roles in the Mechatronics, Biostatistics and Sensors (MeBioS) unit and leadership of the MeBioS Technologies-XCS subdivision. He contributes to Leuven One Health Institute and the KU Leuven Institute for Integration of Micro- and Nano-scale Technologies (LIMNI), while serving on the Faculty Council and Departmental Council for Biosystems. His research focuses on microfluidic systems for biomedical applications, including artificial cell engineering, cystic fibrosis therapies, and organ-on-chip platforms. 2024 Senior Lecturer in Physical Biology and Biomachines 2023-2025 Promotor/Co-promotor for 10+ advanced microfluidics projects 2010-2025 30+ publications in microfluidic manipulation and artificial cells His recent publications demonstrate expertise in droplet-based biological systems, with emphasis on artificial cell creation (biomimetic red blood cell vesicles, synthetic dendritic cells), disease modeling (lung fibrosis, vasculature inflammation), and advanced screening technologies. Collaborations span gene therapy (CFTR correction), cancer immunotherapy (artificial T-cells), and biomedical device development. Key techniques include acoustophoresis, droplet stabilization, and programmable microfluidic platforms.

• Industrial Biotechnology
• Biocatalysis
• Enzyme Engineering
• +۳ مورد دیگر

Dr. Xu Li is a Research Fellow in Industrial Biotechnology at the Department of Chemical Engineering, Faculty of Engineering and Information Technology, University of Melbourne. She works in Dr. Sally Gras' research group and has made significant contributions to biocatalysis, enzyme engineering, and microfluidic technologies. PhD in Chemical Engineering (Monash University) McKenzie Postdoctoral Fellow (University of Melbourne, 2012-2015) Current focus on Escherichia coli biotransformation systems for pharmaceutical production Her research spans multiple domains: Biocatalysis & Enzyme Engineering: Codeine synthesis from thebaine, protein mutagenesis for enhanced biotransformation Microfluidic Diagnostics: Development of paper-based and thread-based analytical devices Biomaterials: Peptide patterning strategies for tissue engineering applications Food Science: Comparative analysis of milk proteins and cheese microstructure Notable awards include: 2012 Eureka Prize for Innovative Use of Technology 2011 Mollie Holman Doctoral Medal (Monash University) 2011 Postgraduate Publications Award (Monash University) Dr. Li's scholarly work (34 publications) demonstrates consistent advancements in biochemical engineering, with recent studies focusing on sustainable opiate production and protein-based material design.

Pradeepraj Durairajمشاهده پروفایل

پژوهشگر ارشد

• Biochemical Engineering
• Biomedical Engineering
• Enzymology
• +۵ مورد دیگر

Pradeepraj Durairaj is a Postdoctoral Fellow at the Ramamoorthy Lab, Department of Chemical and Biomedical Engineering, Florida A&M University and Florida State University. His research focuses on cytochrome P450 enzymes, quorum sensing inhibition, biocatalysis, and biomedical engineering applications. Research Interests Enzymology of cytochrome P450s in human and fungal systems Development of quorum sensing inhibitors for antimicrobial applications Biomanufacturing of extracellular vesicles and lipidomics analysis Drug discovery for neurodegenerative diseases (e.g., Alzheimer's) Use of microbial cell factories for metabolic engineering Key Article Trends His recent publications emphasize biochemical approaches to anticancer agents (2025), bioreactor-based biomanufacturing of organoid-derived vesicles (2025), and neurological implications of brain CYP enzymes (2025). Earlier works (2011–2024) span fungal CYP biocatalysis, biofilm inhibition, and human drug metabolism platforms.

Hannah Levisمشاهده پروفایل

مدرس ارشد

• Tissue Engineering
• Regenerative Medicine
• Ophthalmology
• +۴ مورد دیگر

Dr Hannah Levis is a Senior Lecturer in the Department of Eye and Vision Science at the University of Liverpool's School of Medicine. Her academic career bridges engineering principles with ophthalmological applications, focusing on novel tissue engineering and regenerative medicine strategies for ocular repair and disease treatment. Dr Levis's research program centers on understanding ocular cells in their native niche to determine critical interactions with neighboring cells and the microenvironment. Her work aims to develop optimal culture environments for cell expansion, functional biomaterials for cell delivery, creation of biomimetic tissues, and in vitro models of ocular disease. Key research areas include: Tissue engineering approaches for corneal repair and regeneration Development of bio-synthetic corneal alternatives for transplantation Cell therapies for diabetic retinopathy using endothelial progenitor cells Investigation of corneal endothelial progenitor cells and their potential for repair Creation of in vitro models of ocular disease for therapeutic screening Analysis of Dr Levis's recent publications reveals a strong translational focus with direct clinical applications in corneal transplantation and retinal disease treatment. Her work spans from fundamental biomaterials development to clinical evaluation of surgical techniques, demonstrating a comprehensive bench-to-bedside approach. The research shows particular emphasis on endothelial keratoplasty techniques, quality assurance in corneal transplants, and development of biomimetic models for disease study, with significant contributions to understanding corneal endothelial cell behavior and diabetic retinopathy mechanisms. Dr Levis has secured multiple research grants as principal investigator from prestigious funding bodies including the Medical Research Council (current projects through 2027), Diabetes UK, and Fight for Sight. She actively collaborates with researchers including Rachel Williams (Engineering for Growth), Victoria Kearns, and Elizabeth Laird on interdisciplinary projects at the intersection of engineering and ophthalmology. Her current projects include "Corneal epithelial cell transfer to treat persistent epithelial defect" (MRC, 2024-2027) and "Bio-synthetic corneal endothelial grafts for transplantation" (MRC, 2022-2025). As an educator, Dr Levis teaches on the Structural Biomaterials module in the School of Engineering and serves as Module Co-ordinator for "Clinical Trials Design and Governance." She supervises multiple PhD students including Jessica Eyre (investigating endothelial progenitor cells for diabetic retinopathy), Danielle O'Loughlin (developing bioengineered corneal stroma), and Rami Rasheed Alanazi. Her teaching portfolio spans Anterior Segment Clinical Ophthalmology, COVIS Research Modules, and Posterior Segment Clinical Ophthalmology. Dr Levis is an active member of professional organizations including the Tissue Cell and Engineering Society (TCES) and Association for Research in Vision and Ophthalmology (ARVO), and serves as a MerseySTEM Ambassador.